Dark Forest Capital Management LP Myovant Sciences Ltd. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$24.03 - $27.02 $63,559 - $71,467	-2,645 Reduced 99.81%	5 $0
Q3 2022 Nov 14, 2022	BUY	$11.6 - $20.44 $30,740 - $54,166	2,650 New	2,650 $48,000
Q1 2022 May 13, 2022	SELL	$11.38 - $16.4 $77,429 - $111,585	-6,804 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$14.31 - $23.87 $76,701 - $127,943	5,360 Added 371.19%	6,804 $106,000
Q3 2021 Nov 12, 2021	BUY	$18.94 - $26.99 $27,349 - $38,973	1,444 New	1,444 $32,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.